Evotec SE (EVO) Shareholder's Equity (2019 - 2026)

Evotec SE (EVO) Shareholder's Equity (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 8.23 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.75 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.21 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 446.17 Mn
10 Evotec SE 583.10 Mn 582.58 Mn - 819,077.07

Historic Data

Download Data
DateValue
Mar 31, 2026 819,077.07
Dec 31, 2025 947,186.86
Sep 30, 2025 935,403.06
Jun 30, 2025 957,396.79
Mar 31, 2025 959,466.92
Dec 31, 2024 1.02 Bn
Dec 31, 2023 1.20 Bn
Dec 31, 2022 1.21 Bn
Sep 30, 2022 1.24 Mn
Mar 31, 2022 1.47 Mn
Dec 31, 2021 1.58 Bn
Sep 30, 2021 1.17 Mn
Dec 31, 2020 863.76 Mn
Dec 31, 2019 529.77 Mn